Peng Xiao
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
-
- RNA modifications and cancer 7
- Circular RNAs in diseases 4
- Cell death mechanisms and regulation 3
-
- Cancer-related Molecular Pathways 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- Xu ZhuJin‐Peng SunYuhang ZhangJianqiang LiTiemin PeiQinghui MengXiao ZhangDesen Liang
- Journals
- PLoS ONE (1 paper)Biochemical and Biophysical Research Communications (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- ChinaSwitzerland
In The Last Decade
Peng Xiao
24 papers receiving 399 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 135
- Molecular Biology 228
- Oncology 83
- Rheumatology 43
- Biological Psychiatry 7
Countries citing papers authored by Peng Xiao
This map shows the geographic impact of Peng Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Xiao more than expected).
Fields of papers citing papers by Peng Xiao
This network shows the impact of papers produced by Peng Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Xiao. The network helps show where Peng Xiao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peng Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 6 | |
| 2 | 2022 | 0 | |
| 3 | 2021 | 17 | |
| 4 | 2021 | 22 | |
| 5 | 2020 | 26 | |
| 6 | 2020 | 26 | |
| 7 | 2020 | 1 | |
| 8 | 2020 | 4 | |
| 9 | 2020 | 28 | |
| 10 | MicroRNA-613 alleviates IL-1β-induced injury in chondrogenic CHON-001 cells by targeting fibronectin 1. | 2020 | 13 |
| 11 | 2019 | 73 | |
| 12 | 2019 | 15 | |
| 13 | 2018 | 7 | |
| 14 | 2018 | 7 | |
| 15 | 2017 | 29 | |
| 16 | 2016 | 1 | |
| 17 | 2014 | 18 | |
| 18 | 2012 | 12 | |
| 19 | 2012 | 20 | |
| 20 | 2008 | 6 |
About Peng Xiao
Peng Xiao is a scholar working on Cancer Research, Rheumatology and Oncology, having authored 25 papers that have together received 401 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers), Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (3 papers), Cell death mechanisms and regulation (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Cancer-related Molecular Pathways (3 papers) and Lung Cancer Treatments and Mutations (3 papers). The work is most often cited by research in Cancer Research (135 citations), Molecular Biology (228 citations) and Oncology (83 citations). Peng Xiao has collaborated with scholars based in China and Switzerland. Frequent co-authors include Xu Zhu, Jin‐Peng Sun, Yuhang Zhang, Jianqiang Li, Tiemin Pei, Qinghui Meng, Xiao Zhang, Desen Liang, Liang Guo and Jiaming Sun. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.